Step 1
Compound 1 (100 mg) was dissolved in 1 mL of conc. H2SO4, then 65% HNO3 (4 equiv.) was added. After stirring for 5 h at 80°C, the mixture was slowly diluted with 10 mL of H2O, and neutralized with Na2CO3 until pH=8. The solution was extracted with CH2Cl2 three times, then the organic layers were combined, concentrated and purified by column chromatography to get a light yellow solid in 68% yield.
Step 2
Compound 2 (150 mg) was dissolved in 10 mL of EtOH, then Et3N (0.25 mL), HCOOH (65 μL) and 10% Pd/C (20 mg) were added. The mixture was stirred for 2 h at 80°C, and a crystalline solid formed. The reaction solution was filtered after cooled it down and the residue was Figure S4 . LSS-11 has no effect on transcription factors of MRP1 and MDR1. Western blot analysis of Nrf2, pERα, and PXR. GAPDH or β-actin were used as loading control.
